Etoposide loaded PLGA and PCL nanoparticles II: Biodistribution and pharmacokinetics after radiolabeling with Tc-99m

Drug Delivery

Volumn 15, Issue 5, 2008, Pages 277-287

  Snehalatha, Movva ^a,d   Venugopal, Kolachina ^a   Saha, Ranendra N ^a   Babbar, Anil Kumar ^b   Sharma, Rakesh Kumar ^c  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^c Defence R D Organization   (India)

^d DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Biodistribution; Etoposide; Nanoparticles; Pharmacokinetics; Radiolabeling

Indexed keywords

DRUG CARRIER; ETOPOSIDE; ETOPOSIDE POLYCAPROLACTONE NANOPARTICLE; ETOPOSIDE POLYGLACTIN NANOPARTICLE; NANOPARTICLE; POLYCAPROLACTONE; POLYCAPROLACTONE NANOPARTICLE; POLYGLACTIN; POLYGLACTIN NANOPARTICLE; PURASORB; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG FORMULATION; ISOTOPE LABELING; MALE; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; RABBIT; RADIOACTIVITY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; ETOPOSIDE; INJECTIONS, INTRAVENOUS; ISOTOPE LABELING; LACTIC ACID; MALE; MICE; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; POLYGLYCOLIC ACID; RABBITS; TECHNETIUM; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 50849097566     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802006500     Document Type: Article

References (16)

1. Arulsudar, N., Subramanian, N., Mishra, P., Sharma, R. K., and Murthy, R. S. 2003. Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine. J. Drug Target 11:187-196.
2. Babbar, A., Kashyap, R., and Chauhan, U. P. 1991. A convenient method for the preparation of 99mTc-labelled pentavalent DMSA and its evaluation as a tumour imaging agent. J. Nucl. Biol. Med. 35:100-104.
3. Bhatnagar, A., Singh, A. K., Babbar, A., Soni, N. L., and Singh, T. 1997. Renal imaging with 99Tc(m)-dextran. Nucl. Med. Commun. 18:562-566.
4. Brigger, I., Dubernet, C., and Couvreur, P. 2002. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Del. Rev. 54:631-651.
5. Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., and Benita, S. 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55:R1-R4.
6. Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D., and Speiser, P. 1983. Pharmacokinetics and distribution of a biodegradable drug-carrier. Int. J. Pharm. 15:335-345.
7. Hyung P. J., Kwon, S., Lee, M., Chung, H., Kim, J.-H., Kim, Y.-S., Park, R.-W., Kim, I.-S., Bong Seo, S., Kwon, I. C., and Young Jeong, S. 2006. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity. Biomaterials 27:119-126.
8. Leroux, J. C., Allemann, E., Doelker, E., and Gurny, R. 1995. New approach for the preparation of nanoparticles by an emulsification diffusion method. Eur. J Pharm. Biopharm. 14-18, 41.
9. Leroux, J. C., Doelker, E., and Gurny, R. 1996. The use of drug-loaded nanoparticles in cancer therapy. In: Microencapsulation Methods and Industrial Applications, Benita, S. (Ed.), pp. 535-575. New York: Marcel Dekker, Inc.
10. Mishra, P., Babbar, A., and Chauhan, U. P. 1991. A rapid instant thin layer chromatographic procedure for determining radiochemical purity of 99Tcm-IDA agents. Nucl. Med. Commun. 12:467-469.
11. Moghimi, S. M., and Hunter, A. C. 2001. Capture of stealth nanoparticles by the body's defences. Crit. Rev. Ther. Drug Carrier Syst. 18:527-550.
12. Reddy, L. H., Sharma, R. K., and Murthy, R. S. 2004. Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour. J. Drug. Target 12:443-451.
13. Stolnik, S., Heald, C. R., Neal, J., Garnett, M. C., Davis, S. S., Illum, L., Purkis, S. C., Barlow, R. J., and Gellert, P. R. 2001. Polylactide- poly(ethylene glycol) micellar-like particles as potential drug carriers: Production, colloidal properties and biological performance. J. Drug Target 9:361-378.
14. Theobald, A. E. 1990. Quality control of radiopharmaceuticals. In: Textbook of Radiopharmacy: Theory and Practice, Sampson, C. B. (Ed.), pp. 127-129, New York: Gordon and Breach Science.
15. Verdun, C., Brasseur, F., Vranckx, H., Couvreur, P., and Roland, M. 1990. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles. Cancer Chemother. Pharmacol. 26:13-18.
16. Yu, J. J., Lee, H. A., Kim, J. H., Kong, W. H., Kim, Y., Cui, Z. Y., Park, K. G., Kim, W. S., Lee, H. G., and Seo, S. W. 2007. Bio-distribution and anti-tumor efficacy of PEG/PLA nanoparticles loaded doxorubicin. J. Drug Target 15:279-284.